Data / Companies / ALMR
Alamar Biosciences, Inc.Nasdaq
ALMR-US · CIK 0002104204 · Laboratory Analytical Instruments
Revenue by quarter
US$ · last 8Hover a column for its exact figure
$0$10M$20M$30M
Q1 '25Q2 '25Q1 '26Q2 '26
| Quarter | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $29.4M | -$13.2M | -0.22 |
| Q1 FY2026 | $26.0M | -$21.3M | -1.74 |
| Q2 FY2025 | $16.2M | -$7.0M | -0.62 |
| Q1 FY2025 | $13.1M | -$7.7M | -0.68 |
Newest filings
All 20| Form | Filed | |
|---|---|---|
| 8-K | 1 Sep 2026 | |
| 10-Q | 11 Aug 2026 | |
| 8-K | 10 Aug 2026 | |
| 8-K | 15 Jul 2026 | |
| 10-Q | 8 May 2026 | |
| 8-K | 8 May 2026 | |
| EFFECT | 20 Apr 2026 | |
| S-8 | 20 Apr 2026 |
Description
- Ticker
- ALMR-US
- Exchange
- Nasdaq
- Index
- –
- Industry
- Laboratory Analytical Instruments
- SIC division
- Manufacturing
- CIK
- 0002104204
- Fiscal year ends
- Dec
- Filings held
- 20 since 2026
- 8-K events
- 5
- Shares short
- 2.7M, 15 Oct 2026
Financial statements
The main lines of the income statement, balance sheet and cash flow, by year and by quarter. Each period opens its filing.
0 years · US$ millions
| Fiscal period |
|---|
| Period ending |
| Reported in |
| Report filed |
Ratios
Worked out the same way for every company. Hover a ratio for how it is calculated.
Valuation
- Market cap
- $2.1B
- Price
- $30.59
- Price to book
- 6.79×
- Enterprise value
- $2.0B
- 52-week high
- $38.23
- 52-week low
- $19.09
Profitability
Growth
Balance sheet
- Cash and equivalents
- $133.0M
- Borrowings
- $9.9M
- Net debt
- -$123.0M
- Debt to equity
- 0.03×
- Shareholders' equity
- $312.9M
- Total assets
- $391.0M
Shareholders
- Shares outstanding
- 69,392,766
- Share count, last 12 months
- 0.0%
What the company said with its results
The key points, guidance and management's own words from each of the last four results releases.
No results summary read for this company yet.
Revenue by segment
As the company reports it in the segment note of each annual report: by business, by product and by region, latest year.
This company reports no segment split in its annual report.
Company events
Every 8-K, sorted by the event it reports, with the moment the SEC accepted it in New York time.
Every filing
The company's filings with the SEC, newest first: 20 held. Insider, fund and large-holder filings have their own tables below.
| 1 Sep 2026 | 8-K | 28 Aug 2026 | |
| 11 Aug 2026 | 10-Q | 30 Jun 2026 | |
| 10 Aug 2026 | 8-K | 10 Aug 2026 | |
| 15 Jul 2026 | 8-K | 15 Jul 2026 | |
| 8 May 2026 | 10-Q | 31 Mar 2026 | |
| 8 May 2026 | 8-K | 8 May 2026 | |
| 20 Apr 2026 | EFFECT | – | |
| 20 Apr 2026 | S-8 | – | |
| 20 Apr 2026 | 8-K | 20 Apr 2026 | |
| 20 Apr 2026 | POS AM | – | |
| 16 Apr 2026 | EFFECT | – | |
| 16 Apr 2026 | S-1MEF | – | |
| 16 Apr 2026 | CERT | – | |
| 16 Apr 2026 | S-1/A | – | |
| 15 Apr 2026 | 8-A12B | – | |
| 13 Apr 2026 | S-1/A | – | |
| 27 Mar 2026 | S-1 | – | |
| 12 Mar 2026 | DRS/A | – | |
| 17 Feb 2026 | DRS/A | – | |
| 9 Jan 2026 | DRS | – |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months, with the shares they held after.
| 28 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 948 | $32.47 | $30.8K | 165,005 | 29 Oct 2026 |
| 28 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 814 | $33.11 | $27.0K | 164,191 | 29 Oct 2026 |
| 28 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 35,248 | $32.47 | $1.1M | 6,132,228 | 29 Oct 2026 |
| 28 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 30,249 | $33.11 | $1.0M | 6,101,979 | 29 Oct 2026 |
| 28 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 8,224 | $32.47 | $267.0K | 1,430,839 | 29 Oct 2026 |
| 28 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 7,058 | $33.11 | $233.7K | 1,423,781 | 29 Oct 2026 |
| 28 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 9,846 | $32.47 | $319.7K | 1,713,046 | 29 Oct 2026 |
| 28 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 8,450 | $33.11 | $279.8K | 1,704,596 | 29 Oct 2026 |
| 27 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 134 | $30.33 | $4.1K | 167,304 | 29 Oct 2026 |
| 27 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 943 | $31.33 | $29.5K | 166,361 | 29 Oct 2026 |
| 27 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 408 | $31.88 | $13.0K | 165,953 | 29 Oct 2026 |
| 27 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 4,960 | $30.33 | $150.4K | 6,217,656 | 29 Oct 2026 |
| 27 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 35,049 | $31.33 | $1.1M | 6,182,607 | 29 Oct 2026 |
| 27 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 15,131 | $31.88 | $482.4K | 6,167,476 | 29 Oct 2026 |
| 27 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 1,157 | $30.33 | $35.1K | 1,450,772 | 29 Oct 2026 |
| 27 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 8,178 | $31.33 | $256.2K | 1,442,594 | 29 Oct 2026 |
| 27 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 3,531 | $31.88 | $112.6K | 1,439,063 | 29 Oct 2026 |
| 27 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 1,386 | $30.33 | $42.0K | 1,736,909 | 29 Oct 2026 |
| 27 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 9,791 | $31.33 | $306.8K | 1,727,118 | 29 Oct 2026 |
| 27 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 4,226 | $31.88 | $134.7K | 1,722,892 | 29 Oct 2026 |
| 26 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 2,313 | $30.52 | $70.6K | 167,440 | 27 Oct 2026 |
| 26 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 2 | $31.07 | $62 | 167,438 | 27 Oct 2026 |
| 26 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 86,008 | $30.52 | $2.6M | 6,222,686 | 27 Oct 2026 |
| 26 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 70 | $31.07 | $2.2K | 6,222,616 | 27 Oct 2026 |
| 26 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 20,069 | $30.52 | $612.5K | 1,451,945 | 27 Oct 2026 |
| 26 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 16 | $31.07 | $497 | 1,451,929 | 27 Oct 2026 |
| 26 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 24,027 | $30.52 | $733.3K | 1,738,314 | 27 Oct 2026 |
| 26 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 19 | $31.07 | $590 | 1,738,295 | 27 Oct 2026 |
| 23 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 107 | $29.35 | $3.1K | 172,231 | 27 Oct 2026 |
| 23 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 832 | $30.23 | $25.2K | 171,399 | 27 Oct 2026 |
| 23 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 1,646 | $30.85 | $50.8K | 169,753 | 27 Oct 2026 |
| 23 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 3,975 | $29.35 | $116.7K | 6,400,806 | 27 Oct 2026 |
| 23 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 30,921 | $30.23 | $934.7K | 6,369,885 | 27 Oct 2026 |
| 23 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 61,191 | $30.85 | $1.9M | 6,308,694 | 27 Oct 2026 |
| 23 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 928 | $29.35 | $27.2K | 1,493,506 | 27 Oct 2026 |
| 23 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 7,215 | $30.23 | $218.1K | 1,486,291 | 27 Oct 2026 |
| 23 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 14,277 | $30.85 | $440.4K | 1,472,014 | 27 Oct 2026 |
| 23 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 1,110 | $29.35 | $32.6K | 1,788,073 | 27 Oct 2026 |
| 23 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 8,638 | $30.23 | $261.1K | 1,779,435 | 27 Oct 2026 |
| 23 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 17,094 | $30.85 | $527.4K | 1,762,341 | 27 Oct 2026 |
| 22 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 1,246 | $29.00 | $36.1K | 173,431 | 23 Oct 2026 |
| 22 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 994 | $29.59 | $29.4K | 172,437 | 23 Oct 2026 |
| 22 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 99 | $30.81 | $3.0K | 172,338 | 23 Oct 2026 |
| 22 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 46,290 | $29.00 | $1.3M | 6,445,405 | 23 Oct 2026 |
| 22 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 36,941 | $29.59 | $1.1M | 6,408,464 | 23 Oct 2026 |
| 22 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 3,683 | $30.81 | $113.5K | 6,404,781 | 23 Oct 2026 |
| 22 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 10,800 | $29.00 | $313.2K | 1,503,913 | 23 Oct 2026 |
| 22 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 8,620 | $29.59 | $255.1K | 1,495,293 | 23 Oct 2026 |
| 22 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 859 | $30.81 | $26.5K | 1,494,434 | 23 Oct 2026 |
| 22 Oct 2026 | Qiming Corporate Gp Vi, Ltd.10% owner | Sale outside a trading plan | 12,931 | $29.00 | $375.0K | 1,800,531 | 23 Oct 2026 |
1–50 of 94
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| 14 Oct 2026 | Qiming Managing Directors Fund VI, L.P.Affiliate | 41,945 | $987.0K | 14 Oct 2026 |
| 14 Oct 2026 | Qiming Venture Partners VIII Investments, LLCAffiliate | 363,729 | $8.6M | 14 Oct 2026 |
| 14 Oct 2026 | Qiming Venture Partners VIII-HC, L.P.Affiliate | 435,468 | $10.2M | 14 Oct 2026 |
| 14 Oct 2026 | Qiming Venture Partners VI, L.P.Affiliate | 1,558,858 | $36.7M | 14 Oct 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| 13 Aug 2026 | Yuling Luo | 13G | 6.4% | 4.5M |
| 11 Aug 2026 | Qiming Corporate GP VI, Ltd | 13G | 10.2% | 7.1M |
| 7 Jul 2026 | Sands Capital Life Sciences Pulse Fund II, L.P. | 13D amended | 6.1% | 4.2M |
| 2 Jul 2026 | SHERPA HEALTHCARE FUND II, L.P. | 13G | 7.2% | 5.0M |
| 23 Apr 2026 | Sands Capital Life Sciences Pulse Fund II, L.P. | 13D | 6.3% | 4.2M |
| 23 Apr 2026 | Illumina Innovation Fund II GP, L.L.C. | 13D | 9.6% | 6.4M |
Trades by members of the House
From each member's periodic transaction report: the amount is the band the report gives.
No House trades in this company.
Short interest
Shares sold short and not yet bought back, on every FINRA settlement date.
Shares short, each settlement
| 15 Oct 2026 | 2.7M | -4.79% | 3.14 |
| 30 Sep 2026 | 2.8M | +32.45% | 4.25 |
| 15 Sep 2026 | 2.1M | +0.05% | 7.95 |
| 31 Aug 2026 | 2.1M | +2.2% | 6.53 |
| 14 Aug 2026 | 2.1M | -14.59% | 5.32 |
| 31 Jul 2026 | 2.4M | +8.21% | 11.32 |
| 15 Jul 2026 | 2.2M | -19.52% | 7.58 |
| 30 Jun 2026 | 2.8M | +48.7% | 4.9 |
| 15 Jun 2026 | 1.9M | +6% | 11.46 |
| 29 May 2026 | 1.8M | +4.13% | 6.78 |
1–10 of 12
Funds that hold it
Every fund's holding from its latest Form 13F, largest first, with what it added or trimmed in the quarter.
Funds holding
87
quarter to 30 Jun 2026
Added or new
87
since 31 Mar 2026
Trimmed
0
in the quarter
Largest holder
Sands Capital Alternatives, LLC
$114.6M
The 60 largest of 87 funds, by value
1–50 of 60
Dividends and buybacks
Dividend per share, the cash paid and the shares bought back, each fiscal year.
This company has paid no dividend in the years held.
Peers
Companies in the same industry, largest first, on the same measures.
| Company | Market value | Revenue, 12 months | Revenue growth | Operating margin | Net margin | ROE | P/E | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|
| Alamar Biosciences, Inc.this company | $2.1B | – | – | – | – | – | – | – |
| Agilent Technologies, Inc. | $49.3B | $7.4B | 8.6% | 22.2% | 19.5% | 19.6% | 34.4× | 27.0× |
| Waters Corp. | $45.4B | $4.6B | 52.5% | 7.1% | 3.6% | 1.1% | 115.4× | – |
| Mettler Toledo International Inc. | $36.3B | $4.1B | 6.9% | – | 21.9% | 7062.4% | 37.7× | – |
| Illumina, Inc. | $35.7B | $4.5B | 5.8% | 21.2% | 19.7% | 28.5% | 40.6× | 29.2× |
| Revvity, Inc. | $17.5B | $2.9B | 4.1% | 12.3% | 8.2% | 3.3% | 74.7× | 25.6× |
| Avantor, Inc. | $10.9B | $6.6B | 0.9% | 7.3% | 5.1% | 5.8% | 32.1× | 15.6× |
| Bio-Rad Laboratories, Inc. | $10.0B | $2.6B | 1.4% | 2.1% | 8.6% | 3.1% | 45.2× | – |
| 10x Genomics, Inc. | $9.1B | $616.9M | -4.3% | -14.3% | -12.2% | -9.1% | – | – |
| Bruker Corp. | $8.7B | $3.5B | 1.6% | -0.9% | -2.0% | -3.0% | – | 51.8× |
| Pacific Biosciences of California, Inc. | $808.1M | $159.3M | 2.0% | -83.5% | -82.5% | – | – | – |
What the company does
The description for this company is being written.
Free for your personal research, with credit and a link. For API access, bulk files or commercial use, tell us what you need. The data licence